A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor

NCT06166472 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso